Global Olmesartan Medoxomil (CAS 144689-63-4) Market Outlook 2016-2021

Olmesartan medoxomil, the medoxomil ester of olmesartan, is novel and oral antagonist of angiotensin II TYPE-1 receptor (AT1 receptor) with an inhibition constant IC50 of 33 nmol/L. Through oral administration, olmesartan medoxomil is rapidly absorbed by the gastrointestinal tract converting to its active metabolite olmesartan, whose inhibition constant IC50 towards AT1 receptor is 8 nmol/L. The esterification of olmesartan with medoxomil moiety is just to improve its water solubility (from 4.5% to 28.6%). Olmesartan medoxomil is used for the treatment of hypertension, in which olmesartan dose-dependently reduces the blood pressure through arterial vasodilation and reducing sodium retention.

Request Sample Report Here: http://www.reportbazzar.com/request-sample/?pid=678218&ptitle=Global+Olmesartan+Medoxomil+%28CAS+144689-63-4%29+Market+Outlook+2016-2021&req=Sample

This report provides detailed analysis of worldwide markets for Olmesartan Medoxomil (CAS 144689-63-4) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Olmesartan Medoxomil (CAS 144689-63-4) market and further lays out an analysis of the factors influencing the supply/demand for Olmesartan Medoxomil (CAS 144689-63-4), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC’s report, Global Olmesartan Medoxomil (CAS 144689-63-4) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Olmesartan Medoxomil (CAS 144689-63-4) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Olmesartan Medoxomil (CAS 144689-63-4) market are Daiichi Sankyo (Japan), Taj Pharmaceuticals (India), Divis Laboratories (India), Amoli Organics (India),Lupin (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), Lianyungang Runzhong (China), HEC (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Olmesartan Medoxomil (CAS 144689-63-4) industry has been provided.

Browse Report Summary with TOC: http://www.reportbazzar.com/product/global-olmesartan-medoxomil-cas-144689-63-4-market-outlook-2016-2021/

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW

Enquiry Before Buying: http://www.reportbazzar.com/discount-form/?pid=678218&ptitle=Global+Olmesartan+Medoxomil+%28CAS+144689-63-4%29+Market+Outlook+2016-2021&req=Discount

About Us:
Reportbazzar.com is your trusted source for the most inclusive and informative assortment of market research reports designed to empower you with the latest in industry information that translates to time and cost savings for your business. We not only help you give wing to your latent business ideas but also facilitate you in taking the best informed and strategic decisions that guarantee success in your most promising business endeavors.

Contact Us:
ReportBazzar
Mary Jane
30 Wall Street, 8th floor,
New York, NY 10005.
US: +1 (212) 389-6363
India: +91 20 66528525
Email Id: sales@reportbazzar.com
Website: http://www.reportbazzar.com/

This release was published on openPR.